CD276 and osteosarcoma: (84) reported that PD-1/PD-L1 was not the only immune checkpoint axis in human osteosarcoma lesions; herpesvirus entry mediator (HVEM/CD270) and indeterminate receptor to B7H3/CD276 were also expressed.